Pacira BioSciences, Inc.
PCRX
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
14 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$25.75
Price-1.06%
-$0.27
1Y
Price
Market Cap
$1.171b
Small
Price/Earnings 3y Avg5y Avg
56x
Premium
Premium
Financials Overview
Key metrics over the past few years+19.1%
EBITDA Margin+3.0%
Net Profit Margin+31.7%
Free Cash Flow MarginRevenue
$716.791m
+2.3%
1y CAGR+2.4%
3y CAGR+7.6%
5y CAGREarnings
$21.438m
+121.5%
1y CAGR-17.3%
3y CAGR-28.5%
5y CAGREPS
$0.45
+120.9%
1y CAGR-19.6%
3y CAGR-30.5%
5y CAGRBook Value
$727.214m
$1.298b
Assets$570.363m
Liabilities$425.308m
DebtDebt to Assets
32.8%
2.9x
Debt to EBITDAFree Cash Flow
$124.204m
-30.5%
1y CAGR+6.2%
3y CAGR+15.8%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company